| Financial Year |
March 31 2023 |
| Monetary Funds |
804,060,019.59 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
3,536,724.36 |
| Accounts Receivable |
423,578,078.65 |
| Advances to Suppliers |
8,109.18 |
| Other Receivables |
17,848,375.01 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
386,589,709.75 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,018,061.48 |
| Total Current Assets |
1,699,670,960.14 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
79,139,749.98 |
| Investment Properties |
-- |
| Fixed Assetes |
446,259,916.16 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
140,313,986.86 |
| R&D expenses |
27,668,017.80 |
| Goodwill |
3,540,906.00 |
| Long-Term Deferred and Prepaid Expenses |
1,898,881.34 |
| Deferred Income Tax Assets |
8,830,816.11 |
| Other Non-Current Assets |
17,758,952.76 |
| Sub-Total of Non-Current Assets |
755,471,876.08 |
| Total Assets |
2,455,142,836.22 |
| Short-Term Loans |
409,419,160.83 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
10,180,823.04 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
103,461,524.98 |
| Taxes Payable |
12,064,461.36 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
24,540,123.33 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
21,304,767.45 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
622,683,937.22 |
| Long-term Loans |
90,164,354.17 |
| Bonds Payable |
200,618,284.90 |
| Long-Term Accounts Payable |
30,000,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
5,516,066.46 |
| Deferred Income Tax Liabilities |
661,970.17 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
331,525,348.37 |
| Total Liabilities |
954,209,285.59 |
| Paid-In Capital(Or Share Stock) |
327,134,029.00 |
| Capital Surplus |
719,277,893.55 |
| Surplus Reserve |
70,012,378.25 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
356,228,214.63 |
| Minority Stockholder's Interest |
-5,583,609.64 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,506,517,160.27 |
| Owner's Equity（Stockholder's Equity） |
1,500,933,550.63 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,455,142,836.22 |
